Literature DB >> 24121729

Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice.

Constance Delaby, Vincent Oustric, Caroline Schmitt, Francoise Muzeau, Anne-Marie Robreau, Philippe Letteron, Eric Couchi, Angel Yu, Saïd Lyoumi, Jean-Charles Deybach, Herve Puy, Zoubida Karim, Carole Beaumont, Bernard Grandchamp, Peter Demant, Laurent Gouya.   

Abstract

Disorders of iron metabolism are among the most common acquired and constitutive diseases. Hemochromatosis has a solid genetic basis and in Northern European populations it is usually associated with homozygosity for the C282Y mutation in the HFE protein. However, the penetrance of this mutation is incomplete and the clinical presentation is highly variable. The rare and common variants identified so far as genetic modifiers of HFE-related hemochromatosis are unable to account for the phenotypic heterogeneity of this disorder. There are wide variations in the basal iron status of common inbred mouse strains, and this diversity may reflect the genetic background of the phenotypic diversity under pathological conditions. We therefore examined the genetic basis of iron homeostasis using quantitative trait loci mapping applied to the HcB-15 recombinant congenic strains for tissue and serum iron indices. Two highly significant QTL containing either the N374S Mon1a mutation or the Ferroportin locus were found to be major determinants in spleen and liver iron loading. Interestingly, when considering possible epistatic interactions, the effects of Mon1a on macrophage iron export are conditioned by the genotype at the Slc40a1 locus. Only mice that are C57BL/10ScSnA homozygous at both loci display a lower spleen iron burden. Furthermore, the liver-iron lowering effect of the N374S Mon1a mutation is observed only in mice that display a nonsense mutation in the Ceruloplasmin (Cp) gene. This study highlights the existence of genetic interactions between Cp, Mon1a, and the Slc40a1 locus in iron metabolism, suggesting that epistasis may be a crucial determinant of the variable biological and clinical presentations in iron disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24121729     DOI: 10.1007/s00335-013-9479-6

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  40 in total

1.  Mon1a protein acts in trafficking through the secretory apparatus.

Authors:  Dustin C Bagley; Prasad N Paradkar; Jerry Kaplan; Diane M Ward
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.

Authors:  Sara Pelucchi; Raffaella Mariani; Stefano Calza; Anna Ludovica Fracanzani; Giulia Litta Modignani; Francesca Bertola; Fabiana Busti; Paola Trombini; Mirella Fraquelli; Gian Luca Forni; Domenico Girelli; Silvia Fargion; Claudia Specchia; Alberto Piperno
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

3.  Multiple polymorphic loci determine basal hepatic and splenic iron status in mice.

Authors:  Gemma R Grant; Susan W Robinson; Richard E Edwards; Bruce Clothier; Reginald Davies; David J Judah; Karl W Broman; Andrew G Smith
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

4.  Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis.

Authors:  S Distante; M Elmberg; K B Foss Haug; R Ovstebø; J P Berg; P Kierulf; R Hultcrantz; H Bell
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

Review 5.  Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

Authors:  Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

6.  HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.

Authors:  C Mura; O Raguenes; C Férec
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

7.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

8.  In silico QTL mapping of basal liver iron levels in inbred mouse strains.

Authors:  Stela McLachlan; Seung-Min Lee; Teresa M Steele; Paula L Hawthorne; Matthew A Zapala; Eleazar Eskin; Nicholas J Schork; Gregory J Anderson; Chris D Vulpe
Journal:  Physiol Genomics       Date:  2010-11-09       Impact factor: 3.107

9.  A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.

Authors:  Clare C Constantine; Greg J Anderson; Chris D Vulpe; Christine E McLaren; Melanie Bahlo; Heng Lin Yeap; Dorota M Gertig; Nicholas J Osborne; Nadine A Bertalli; Kenneth B Beckman; Victoria Chen; Pavel Matak; Andrew T McKie; Martin B Delatycki; John K Olynyk; Dallas R English; Melissa C Southey; Graham G Giles; John L Hopper; Katrina J Allen; Lyle C Gurrin
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

10.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume.

Authors:  Beben Benyamin; Manuel A R Ferreira; Gonneke Willemsen; Scott Gordon; Rita P S Middelberg; Brian P McEvoy; Jouke-Jan Hottenga; Anjali K Henders; Megan J Campbell; Leanne Wallace; Ian H Frazer; Andrew C Heath; Eco J C de Geus; Dale R Nyholt; Peter M Visscher; Brenda W Penninx; Dorret I Boomsma; Nicholas G Martin; Grant W Montgomery; John B Whitfield
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.